Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Current therapy of myelodysplastic syndromes.

    ... approval of azacitidine , decitabine , and lenalidomide in the last decade was a major breakthrough. Nonetheless, the ...

    Research Article last updated 09/03/2013 - 12:03pm.

  2. Thrombopoiesis-stimulating agents and myelodysplastic syndromes

    ... therapies, such as azacitidine or lenalidomide . The recombinant human erythropoietin (rHuEPO) ...

    Research Article last updated 03/04/2015 - 10:20am.

  3. More is better: Combination therapies for myelodysplastic syndromes

    ... are currently three FDA-approved medications for MDS; lenalidomide , azacitidine , and decitabine . The role of ...

    Research Article last updated 03/03/2015 - 2:41pm.

  4. Established and novel agents for myelodysplastic syndromes

    ... abnormality or those who fail these initial approaches, lenalidomide may be tried, as can experimental agents. Lower-risk patients ...

    Research Article last updated 03/03/2015 - 1:10pm.

  5. Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease

    ... of patients with MDS: immunomodulatory agents ( lenalidomide ), and hypomethylating therapy [HMT ( decitabine and ...

    Research Article last updated 01/20/2015 - 12:52pm.

  6. Incidence and Burden of the Myelodysplastic Syndromes

    ... despite strong evidence that hypomethylating agents and lenalidomide significantly reduce transfusion burden. Other unmet needs ...

    Research Article last updated 10/14/2015 - 8:44am.

  7. Recent developments in myelodysplastic syndromes

    ... of azacitidine , decitabine , and lenalidomide between 2004 and 2006 seemed to herald a new era in the ...

    Research Article last updated 10/02/2014 - 10:30am.

  8. The Myelodysplastic Syndromes: The Era Of Understanding

    ... spite of this, it has become clear that treatment with lenalidomide and azanucleotides can lead to increased overall survival in ...

    Research Article last updated 09/24/2014 - 11:05am.

  9. Update on the pharmacotherapy for myelodysplastic syndromes

    ... drugs for the treatment of these complex malignancies: lenalidomide , azacitidine and decitabine . AREAS ...

    Research Article last updated 08/21/2014 - 9:23am.

  10. Molecular pathogenesis of myelodysplastic syndromes

    ... approved therapeutic options for MDS, including lenalidomide , decitabine , and 5-azacytidine, are targeted to ...

    Research Article last updated 05/22/2014 - 10:05am.